Associate Professor Ian Davis
Position:
- Medical oncologist, Austin Health
- Head, Uro-Oncology Laboratory, Ludwig Institute for Cancer Research (LICR)
- Associate Member, Ludwig Institute for Cancer Research
- Chair, ANZUP Cancer Trials Group Ltd
- Associate Professor, University of Melbourne
- Adjunct Associate Professor, Monash University
Websites:
Biography:
A/Prof Ian Davis is a medical oncologist working at Austin Health and the Ludwig Institute for Cancer Research in Melbourne, Australia, where he is Head of the Uro-Oncology Laboratory. He is an Associate Member of the Ludwig Institute foA/Prof Ian Davis is a medical oncologist working at Austin Health and the Ludwig Institute for Cancer Research in Melbourne, Australia, where he is Head of the Uro-Oncology Laboratory. He is an Associate Member of the Ludwig Institute for Cancer Research, an Associate Professor of the University of Melbourne, and Adjunct Associate Professor of Monash University. His primary clinical interests are in urologic cancer and in melanoma, and his primary research interests are in cancer immunology and the biology of urologic cancers.
A/Prof Davis is a member of the Urology Committee, Skin Cancer Committee and Standing Subcommittee on Research for the Cancer Council Victoria. He is the founder of the Urologic Oncology Group of the Clinical Oncological Society of Australia (COSA), a member of COSA Council and COSA Executive, and is founder of the Australian and New Zealand Urogenital and Prostate Cancer Trials Group Ltd (ANZUP). He is chair of the ANZUP Board and of its Scientific Advisory Committee. He holds a Clinical Researcher Fellowship from the Victorian Cancer Agency, and an Honorary Practitioner Fellowship of the Australian National Health and Medical Research Council.
abiraterone, cancer biology, cancer immunology, cancer stem cells, cancer therapy, castrate resistance, clinical, clinical trials, dendritic cells, immune escape, immunotherapy, oncology, positron emission tomography, systemic therapies, targeted therapy, translational research, tumor immunology, tumour microenvironment, urologic cancer biology, vaccines.
